Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -4.89% is 256% below its 5-year average of -1.37%, near the low end of its 5-year range (-4.89%–0.94%).
1024.14% below its 12-month average of -0.43%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -3.95%.
RETURN ON ASSETS (ROA)
-4.89%
RETURN ON ASSETS (ROA) AVG TTM
-0.43%
RETURN ON ASSETS (ROA) AVG 3Y
-0.87%
RETURN ON ASSETS (ROA) AVG 5Y
-1.37%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-1024.14%
CURRENT VS 3Y AVG
-463.69%
CURRENT VS 5Y AVG
-256.07%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+84.84%
vs the sector median at left
Certara, Inc.
Market Cap
$1.44B
Return on Assets (ROA)
-4.89%
TTM Avg
-0.43%
3Y Avg
-0.87%
5Y Avg
-1.37%
Market Cap
$1.45B
Return on Assets (ROA)
14.98%
TTM Avg
6.07%
3Y Avg
5.42%
5Y Avg
6.72%
Market Cap
$1.42B
Return on Assets (ROA)
-46.39%
TTM Avg
-37.70%
3Y Avg
-40.46%
5Y Avg
-33.71%
Market Cap
$1.46B
Return on Assets (ROA)
-25.13%
TTM Avg
-5.66%
3Y Avg
-57.10%
5Y Avg
-57.10%
Market Cap
$1.42B
Return on Assets (ROA)
61.75%
TTM Avg
-16.82%
3Y Avg
-22.73%
5Y Avg
-17.45%
Market Cap
$1.48B
Return on Assets (ROA)
-16.72%
TTM Avg
-18.71%
3Y Avg
-15.50%
5Y Avg
-12.14%
Market Cap
$1.40B
Return on Assets (ROA)
-31.81%
TTM Avg
-43.72%
3Y Avg
-70.87%
5Y Avg
-63.61%
Market Cap
$1.40B
Return on Assets (ROA)
-21.52%
TTM Avg
-21.52%
3Y Avg
-21.52%
5Y Avg
-21.52%
Market Cap
$1.48B
Return on Assets (ROA)
6.64%
TTM Avg
5.09%
3Y Avg
3.45%
5Y Avg
4.26%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Certara, Inc. (CERT) | $1.44B | -4.89% | -0.43% | -0.87% | -1.37% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 14.98% | 6.07% | 5.42% | 6.72% |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.42B | -46.39% | -37.70% | -40.46% | -33.71% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | -25.13% | -5.66% | -57.10% | -57.10% |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 61.75% | -16.82% | -22.73% | -17.45% |
| GH Research PLC (GHRS)vs › | $1.48B | -16.72% | -18.71% | -15.50% | -12.14% |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.40B | -31.81% | -43.72% | -70.87% | -63.61% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | -21.52% | -21.52% | -21.52% | -21.52% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | 6.64% | 5.09% | 3.45% | 4.26% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.40B | N/A | N/A | N/A | N/A |
ROA
-4.9%
ROE
-7.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -0.10% |
| 2024-12-31 | -0.77% |
| 2023-12-31 | -3.54% |
| 2022-12-31 | 0.94% |
| 2021-12-31 | -0.88% |
| 2020-12-31 | -3.89% |
| 2019-12-31 | -0.86% |
| 2018-12-31 | -3.16% |
